Lung cancer Patients' own immune cells could be new weapon
NCT ID NCT07202611
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 25 times
Summary
This early-phase study tests whether a personalized cell therapy is safe for people with advanced non-small cell lung cancer. Researchers take immune cells (dendritic and natural killer cells) from the patient, grow them in a lab, and inject them back. The goal is to see if this approach can control the disease without serious side effects. Ten participants who have already tried at least two other treatments will be enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER (NSCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital Yunlin Branch
RECRUITINGHuwei, YUNLIN, 640, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.